Report ID: SQMIG35A2810
Report ID:
SQMIG35A2810 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|
Tables:
59 |
Figures:
75
In the year 2022, North America held a significant share in the vascular closure device market, recording revenues surpassing USD 689 million. The region is poised for sustained growth until 2032, primarily driven by the heightened prevalence of cardiovascular diseases. The expanding population of elderly individuals, who exhibit a greater susceptibility to cardiovascular ailments, has prompted the establishment of advanced healthcare infrastructure in the region. Furthermore, the presence of extensive reimbursement coverage for medical procedures acts as a compelling incentive for both healthcare professionals and patients. This, in turn, encourages the adoption of innovative treatment alternatives and contributes substantially to the overall progress and advancement of the market.
Asia Pacific is anticipated to exhibit rapid growth throughout the forecast period. Anticipated as the region with the most rapid growth over the next seven years, Asia Pacific is propelled by the emerging economies of China and India. The presence of untapped areas and unmet patient needs has garnered substantial attention from industry players, becoming pivotal factors fueling growth in this dynamic region. Key players from various regions are strategically expanding their product portfolios to establish a foothold in untapped territories, thereby contributing to the overall growth trajectory in Asia Pacific.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2810